Cite
HARVARD Citation
Boutry, C. et al. (2022). The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70. Clinical infectious diseases. pp. 1459-1467. [Online].